What are the Cornell criteria used for in diagnosing acute myocardial infarction (AMI) in patients with left bundle branch block (LBBB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cornell Criteria for Diagnosing AMI in LBBB

The term "Cornell criteria" does not exist in the medical literature for diagnosing acute myocardial infarction in patients with left bundle branch block—you are likely referring to the Sgarbossa criteria, which are the validated ECG criteria used for this purpose. 1

The Sgarbossa Criteria

The Sgarbossa criteria were developed from the GUSTO-I trial and consist of three weighted ECG findings that help identify AMI in the presence of LBBB 1:

Primary Criteria (High Specificity)

  • ST-segment elevation ≥1 mm concordant with the QRS complex (same direction as the major QRS deflection)

    • Sensitivity: 73%, Specificity: 92% 1
    • This is the most reliable single criterion 1
  • ST-segment depression ≥1 mm in leads V1-V3 (concordant with predominantly negative QRS)

    • Sensitivity: 25%, Specificity: 96% 1
  • ST-segment elevation ≥5 mm discordant from the QRS complex (opposite direction from major QRS deflection)

    • Sensitivity: 19%, Specificity: 82% 1
    • Note: This criterion has lower specificity and recent evidence suggests it may have very low diagnostic utility 1

Scoring System

A Sgarbossa score ≥3 points indicates high likelihood of AMI 2:

  • Concordant ST elevation ≥1 mm = 5 points
  • Concordant ST depression ≥1 mm in V1-V3 = 3 points
  • Discordant ST elevation ≥5 mm = 2 points

Patients with scores ≥3 have significantly higher 30-day mortality (23.5% vs 7.7%) compared to those with scores <3 2.

Clinical Application Algorithm

Step 1: Initial Assessment

  • Obtain 12-lead ECG within 10 minutes of first medical contact 1, 3
  • Recognize that LBBB occurs in only 2.8% of patients with suspected ACS, and only 30% of these will have AMI 4

Step 2: Apply Sgarbossa Criteria

  • Look specifically for concordant ST elevation ≥1 mm (highest specificity >90%) 1, 3
  • Check for concordant ST depression in V1-V3 1
  • Do not rely on discordant ST changes alone as they have poor diagnostic accuracy 1

Step 3: Integrate with Troponin Testing

  • Combine ECG criteria with high-sensitivity troponin at 0/1 hour or 0/2 hours for optimal diagnostic accuracy (AUC 0.89-0.91) 4
  • This combined approach identifies 97-100% of AMI cases in LBBB 4

Step 4: Management Decision

  • If Sgarbossa criteria are met OR high clinical suspicion persists despite negative criteria, proceed immediately to emergency coronary angiography with intent for primary PCI 1, 3
  • Target first medical contact-to-device time ≤90 minutes 1, 3
  • If PCI unavailable and symptom onset <3 hours, consider fibrinolytic therapy 3

Critical Pitfalls to Avoid

Do not assume new LBBB equals AMI 1, 3:

  • New or presumably new LBBB should NOT be considered diagnostic of AMI in isolation 1
  • Clinical correlation is mandatory 1
  • Most LBBB patients in the ED do not have acute coronary occlusion 1

Do not withhold evaluation based on negative Sgarbossa criteria 5:

  • ECG criteria have low sensitivity (1-12%) but high specificity (95-100%) 4
  • Treating all LBBB patients with chest pain would result in unnecessary treatment of many without AMI 5
  • Serial ECGs should be performed when clinical suspicion remains high 1, 3

Do not forget to obtain comparison ECG 1:

  • A previous ECG showing pre-existing LBBB significantly aids interpretation 1

Modified Sgarbossa Criteria

Recent research suggests using proportional discordance (ST elevation ≥25% of the depth of the preceding S-wave) may improve sensitivity while maintaining specificity 6, though this has not been validated in ventricular pacing and is not yet incorporated into major guidelines 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.